Deprivation Amblyopia and Congenital Hereditary Cataract

References

• Holmes JM, Clarke MP. Amblyopia. Lancet 2006;367(9519):1343–1351
   PubMed Web of Science ®Google Scholar
• Holmes JM, Repka MX, Kraker RT, Clarke MP. The treatment of amblyopia. Strabismus 2006;14(1):37–42
   PubMedGoogle Scholar
• Smith LK, Thompson JR, Woodruff G, Hiscox F. Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1995;32(2):98–101
   PubMedGoogle Scholar
• Carlton J, Kaltenthaler E. Amblyopia and quality of life: A systematic review. Eye (Lond) 2011;25(4):403–413
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, Eijkemans MJ, Vingerling JR, et al. Risk of bilateral visual impairment in individuals with amblyopia: The Rotterdam study. Br J Ophthalmol 2007;91(11):1450–1451
   PubMed Web of Science ®Google Scholar
• Nilsso J. The negative impact of amblyopia from a population perspective: Untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment. Br J Ophthalmol 2007;91(11):1417–1418
   PubMedGoogle Scholar
• Hess RF, Baker CL, Verhoeve JN, et al. The pattern evoked electroretinogram: Its variability in normals and its relationship to amblyopia. Invest Ophthal Visual Sci 1985;26:1610–1623
   PubMed Web of Science ®Google Scholar
• Hubel DH, Wiesel TN. Binocular interaction in striate cortex of kittens reared with artificial squint. J Neurophysiol 1965;28(6):1041–1052
   PubMedGoogle Scholar
• Thompson B, Mansouri B, Koski L, Hess RF. Brain plasticity in the adult: Modulation of function in amblyopia with rTMS. Curr Biol 2008;18(14):1067–1071
   PubMedGoogle Scholar
• Hess RF, Howell ER. The threshold contrast sensitivity function in strabismic amblyopia: Evidence for a two type classification. Vision Res 1977;17(9):1049–1055
   PubMedGoogle Scholar
• Simmers AJ, Ledgeway T, Hess RF, McGraw PV. Deficits to global motion processing in human amblyopia. Vision Res 2003;43(6):729–738
   PubMedGoogle Scholar
• Thompson B, Villeneuve MY, Casanova C, Hess RF. Abnormal cortical processing of pattern motion in amblyopia: Evidence from fMRI. Neuroimage 2012;60(2):1307–1315
   PubMedGoogle Scholar
• Li J, Thompson B, Lam CS, et al. The role of suppression in amblyopia. Invest Ophthalmol Vis Sci 2011 Jun 13;52(7):4169--76
   Google Scholar
• McKee SP, Levi DM, Movshon JA. The pattern of visual deficits in amblyopia. J Vis 2003;3(5):380–405
   PubMedGoogle Scholar
• Wong AM. New concepts concerning the neural mechanisms of amblyopia and their clinical implications. Can J Ophthalmol 2012;47(5):399–409
   PubMed Web of Science ®Google Scholar
• Buch H, Vinding T, La Cour M, Nielsen NV. The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. Acta Ophthalmol Scand 2001;79(5):441–449
   PubMedGoogle Scholar
• Group PEDI. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120(3):268–278
   PubMedGoogle Scholar
• Repka MX, Wallace DK, Beck RW, et al. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005;123(2):149–157
   PubMedGoogle Scholar
• Scheiman MM, Hertle RW, Kraker RT, et al. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: A randomized trial. Arch Ophthalmol 2008;126(12):1634–1642
   PubMedGoogle Scholar
• Koklanis K, Abel LA, Aroni R. Psychosocial impact of amblyopia and its treatment: a multidisciplinary study. Clin Exp Ophthalmol 2006;34(8):743–750
   PubMed Web of Science ®Google Scholar
• Packwood EA, Cruz OA, Rychwalski PJ, Keech RV. The psychosocial effects of amblyopia study. J AAPOS: The Official Publication of the Am Assoc Pediatric Ophthalmol Strabismus/Am Assoc Pediatric Ophthalmol Strabismus 1999;3(1):15–17
   Google Scholar
• Anstice N, Spink J, Abdul-Rahman A. Review of preschool vision screening referrals in South Auckland, New Zealand. Clin Exp Optom 2012;95(4):442–448
   PubMed Web of Science ®Google Scholar
• Awan M, Proudlock FA, Grosvenor D, et al. An audit of the outcome of amblyopia treatment: A retrospective analysis of 322 children. Br J Ophthalmol 2010;94(8):1007–1011
   PubMedGoogle Scholar
• Bhola R, Keech RV, Kutschke P, et al. Recurrence of amblyopia after occlusion therapy. Ophthalmology. 2006;113(11):2097–2100
   PubMedGoogle Scholar
• Holmes JM, Beck RW, Kraker RT, et al. Risk of amblyopia recurrence after cessation of treatment. J AAPOS: The Official Publication of the Am Assoc Pediatric Ophthalmol Strabismus/Am Assoc Pediatric Ophthalmol Strabismus 2004;8(5):420–428
   Google Scholar
• Hess RF, Mansouri B, Thompson B. Restoration of binocular vision in amblyopia. Strabismus 2011;19(3):110–118
   PubMedGoogle Scholar
• Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002 Mar;120(3):268--78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11879129
   Google Scholar
• Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005;123(4):437–447
   PubMedGoogle Scholar
• Rahi J, Logan S, Timms C, et al. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: A population-based study. Lancet 2002;360(9333):597–602
   PubMed Web of Science ®Google Scholar
• Nilsson J. The negative impact of amblyopia from a population perspective: Untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment. Br J Ophthalmol 2007;91(11):1417–1418
   PubMedGoogle Scholar
• Sabri K, Knapp CM, Thompson JR, Gottlob I. The VF-14 and psychological impact of amblyopia and strabismus. Invest Ophthalmol Vis Sci 2006;47(10):4386–4392
   PubMedGoogle Scholar
• van de Graaf ES, van der Sterre GW, Polling JR, et al. Amblyopia & Strabismus Questionnaire: Design and initial validation. Strabismus 2004;12(3):181–193
   PubMedGoogle Scholar
• Carlton J, Kaltenthaler E. Health-related quality of life measures (HRQoL) in patients with amblyopia and strabismus: A systematic review. Br J Ophthalmol 2011;95(3):325–330
   PubMedGoogle Scholar
• Adams GG, Karas MP. Effect of amblyopia on employment prospects. Br J Ophthalmol 1999;83(3):380
   PubMedGoogle Scholar
• Grant S, Melmoth DR, Morgan MJ, Finlay AL. Prehension deficits in amblyopia. Invest Ophthalmol Vis Sci 2007;48(3):1139–1148
   PubMed Web of Science ®Google Scholar
• Wilson GA, Welch D. Does amblyopia have a functional impact? Findings from the Dunedin Multidisciplinary Health and Development Study. Clin Experiment Ophthalmol 2013 Mar;41(2):127--134
   Google Scholar
• Webber AL, Wood JM, Gole GA, Brown B. The effect of amblyopia on fine motor skills in children. Invest Ophthalmol Vis Sci 2008;49(2):594–603
   PubMedGoogle Scholar
• Niechwiej-Szwedo E, Goltz HC, Chandrakumar M, et al. Effects of anisometropic amblyopia on visuomotor behavior, part 2: Visually guided reaching. Invest Ophthalmol Vis Sci 2011;52(2):795–803
   PubMed Web of Science ®Google Scholar
• Niechwiej-Szwedo E, Goltz HC, Chandrakumar M, et al. Effects of anisometropic amblyopia on visuomotor behavior. III: Temporal eye-hand coordination during reaching. Invest Ophthalmol Vis Sci 2011;52(8):5853–5861
   PubMedGoogle Scholar
• Feigenbaum A. Early history of cataract and the ancient operation for cataract. Am J Ophthalmol 1960;49:305–326
   PubMedGoogle Scholar
• Foster A, Gilbert C, Rahi J. Epidemiology of cataract in childhood: A global perspective. J Cataract Refract Surg 1997;23(Suppl 1):601–604
   PubMed Web of Science ®Google Scholar
• Long V, Chen S, Hatt S. Surgical interventions for bilateral congenital cataract. Cochrane Database Syst Rev 2006;3:CD003171
   Google Scholar
• Holmes JM, Leske DA, Burke JP, Hodge DO. Birth prevalence of visually significant infantile cataract in a defined U.S. population. Ophthalmic Epidemiol 2003;10(2):67–74
   PubMed Web of Science ®Google Scholar
• Birch EE, Cheng C, Vu C, Stager DR Jr. Oral reading after treatment of dense congenital unilateral cataract. J AAPOS 2010;14(3):227–231
   PubMedGoogle Scholar
• Magli A, Forte R, Rombetto L. Long-term outcome of primary versus secondary intraocular lens implantation after simultaneous removal of bilateral congenital cataract. Graefes Arch Clin Exp Ophthalmol 2013;251(1):309–314
   PubMed Web of Science ®Google Scholar
• Chak M, Wade A, Rahi JS, British Congenital Cataract Interest G. Long-term visual acuity and its predictors after surgery for congenital cataract: Findings of the British congenital cataract study. Invest Ophthalmol Vis Sci. 2006;47(10):4262–4269
   Google Scholar
• Chen YC, Hu AC, Rosenbaum A, et al. Long-term results of early contact lens use in pediatric unilateral aphakia. Eye Contact Lens 2010;36(1):19–25
   PubMedGoogle Scholar
• Wirth MG, Russell-Eggitt IM, Craig JE, et al. Aetiology of congenital and paediatric cataract in an Australian population. Br J Ophthalmol 2002;86(7):782–786
   PubMed Web of Science ®Google Scholar
• Kinoshita JH. Cataracts in galactosemia. The Jonas S. Friedenwald Memorial Lecture. Invest Ophthalmol 1965;4(5):786–799
   PubMedGoogle Scholar
• Wilson WA, Donnell GN. Cataracts in galactosemia. AMA Arch Ophthalmol 1958;60(2):215–222
   PubMedGoogle Scholar
• Morner CT. Untersuchungen der Protein substanzenin den lichtbrechenden Medien des Auges. Z Physiol Chem 1893;18:61–106
   Google Scholar
• Bhat SP. Crystallins, genes and cataract. Prog Drug Res 2003;60:205–262
   PubMedGoogle Scholar
• Brady JP, Garland D, Duglas-Tabor Y, et al. Targeted disruption of the mouse alpha A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B-crystallin. Proc Natl Acad Sci U S A 1997;94(3):884–889
   PubMedGoogle Scholar
• Litt M, Kramer P, LaMorticella DM, et al. Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet 1998;7(3):471–474
   PubMedGoogle Scholar
• Devi RR, Yao W, Vijayalakshmi P, et al. Crystallin gene mutations in Indian families with inherited pediatric cataract. Mol Vis 2008;14:1157–1170
   PubMed Web of Science ®Google Scholar
• Khan AO, Aldahmesh MA, Meyer B. Recessive congenital total cataract with microcornea and heterozygote carrier signs caused by a novel missense CRYAA mutation (R54C). Am J Ophthalmol 2007;144(6):949–952
   PubMedGoogle Scholar
• Pras E, Frydman M, Levy-Nissenbaum E, et al. A nonsense mutation (W9X) in CRYAA causes autosomal recessive cataract in an inbred Jewish Persian family. Invest Ophthalmol Vis Sci 2000;41(11):3511–3515
   PubMed Web of Science ®Google Scholar
• Igarashi S, Takiyama Y, Cancel G, et al. Intergenerational instability of the CAG repeat of the gene for Machado-Joseph Disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat. Hum Mol Genet 1996;5(7):923–932
   Google Scholar
• Litt M, Carrero-Valenzuela R, LaMorticella DM, et al. Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. Hum Mol Genet 1997;6(5):665–668
   PubMedGoogle Scholar
• Conley YP, Erturk D, Keverline A, et al. A juvenile-onset, progressive cataract locus on chromosome 3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2. Am J Hum Genet 2000;66(4):1426–1431
   PubMedGoogle Scholar
• Jakobs PM, Hess JF, FitzGerald PG, et al. Autosomal-dominant congenital cataract associated with a deletion mutation in the human beaded filament protein gene BFSP2. Am J Hum Genet 2000;66(4):1432–1436
   PubMedGoogle Scholar
• Brooks SP, Ebenezer ND, Poopalasundaram S, et al. Identification of the gene for Nance-Horan syndrome (NHS). J Med Genet 2004;41(10):768–771
   PubMedGoogle Scholar
• Kerscher S, Church RL, Boyd Y, Lyon MF. Mapping of four mouse genes encoding eye lens-specific structural, gap junction, and integral membrane proteins: Cryba1 (crystallin beta A3/A1), Crybb2 (crystallin beta B2), Gja8 (MP70), and Lim2 (MP19). Genomics 1995;29(2):445–450
   PubMed Web of Science ®Google Scholar
• Dahm R, van Marle J, Prescott AR, Quinlan RA. Gap junctions containing alpha8-connexin (MP70) in the adult mammalian lens epithelium suggests a re-evaluation of its role in the lens. Exp Eye Res 1999;69(1):45–56
   PubMedGoogle Scholar
• Dahm R. Lens fibre cell differentiation: A link with apoptosis? Ophthalmic Res 1999;31(3):163–183
   PubMedGoogle Scholar
• Korlimbinis A, Berry Y, Thibault D, et al. Protein aging: truncation of aquaporin 0 in human lens regions is a continuous age-dependent process. Exp Eye Res 2009;88(5):966–973
   PubMed Web of Science ®Google Scholar
• Francis P, Chung JJ, Yasui M, et al. Functional impairment of lens aquaporin in two families with dominantly inherited cataracts. Hum Mol Genet 2000;9(15):2329–2334
   PubMedGoogle Scholar
• Pras E, Levy-Nissenbaum E, Bakhan T, et al. A missense mutation in the LIM2 gene is associated with autosomal recessive presenile cataract in an inbred Iraqi Jewish family. Am J Hum Genet 2002;70(5):1363–1367
   PubMedGoogle Scholar
• Favor J, Peters H, Hermann T, et al. Molecular characterization of Pax6(2Neu) through Pax6(10Neu): An extension of the Pax6 allelic series and the identification of two possible hypomorph alleles in the mouse Mus musculus. Genetics 2001;159(4):1689–1700
   PubMedGoogle Scholar
• Glaser T, Jepeal L, Edwards JG, et al. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet 1994;7(4):463–471
   PubMed Web of Science ®Google Scholar
• Zaidman G. Peters' anomaly. Ophthalmic Genet 2004;25(2):157–158 ; author reply 158
   PubMedGoogle Scholar
• Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 1991;113(4):1435–1449
   PubMed Web of Science ®Google Scholar
• St-Onge L, Sosa-Pineda B, Chowdhury K, et al. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 1997;387(6631):406–409
   PubMed Web of Science ®Google Scholar
• Semina EV, Ferrell RE, Mintz-Hittner HA, et al. A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nat Genet 1998;19(2):167–170
   PubMedGoogle Scholar
• Semina EV, Brownell I, Mintz-Hittner HA, et al. Mutations in the human forkhead transcription factor FOXE3 associated with anterior segment ocular dysgenesis and cataracts. Hum Mol Genet 2001;10(3):231–236
   PubMedGoogle Scholar
• Bremond-Gignac D, Bitoun P, Reis LM, et al. Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia. Mol Vis 2010;16:1705–1711
   PubMed Web of Science ®Google Scholar
• Nishimura DY, Searby CC, Alward WL, et al. A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet 2001;68(2):364–372
   PubMed Web of Science ®Google Scholar
• Bu L, Jin Y, Shi Y, et al. Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract. Nat Genet 2002;31(3):276–278
   PubMed Web of Science ®Google Scholar
• Mellersh CS, Graves KT, McLaughlin B, et al. Mutation in HSF4 associated with early but not late-onset hereditary cataract in the Boston Terrier. J Hered 2007;98(5):531–533
   PubMedGoogle Scholar
• Cooper MA, Son AI, Komlos D, et al. Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci U S A 2008;105(43):16620–16625
   PubMedGoogle Scholar